Global COVID-19 RNA Vaccine Market Growth (Status and Outlook) 2023-2029

March 2023 | 75 pages | ID: GEECE897E277EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, usually wrapped in lipid nanoparticles.They fuse with cells.Once inside the cell, the RNA sequence is translated by the ribosome into a protein or part of a protein.

According to this study, the global COVID-19 RNA Vaccine market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 RNA Vaccine market by product type, application, key players and key regions and countries.

Segmentation by product type:

• Being Developed
• Preclinical
• Clinical I
• Clinical II

Segmentation by Application:

• Pharmaceutical And Biotechnology Companies
• Hospital
• Academic And Research Organizations
• Other

This report also splits the market by region:

• United States
• China
• Europe
• Other regions:
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• MODERNA
• CureVac
• Zydus Cadila
• BioNTech
• Stermirna

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global COVID-19 RNA Vaccine Market Size 2024-2029
  2.1.2 COVID-19 RNA Vaccine Market Size CAGR by Region
2.2 COVID-19 RNA Vaccine Segment by Type
  2.2.1 Being Developed
  2.2.2 Preclinical
  2.2.3 Clinical I
  2.2.4 Clinical II
2.3 COVID-19 RNA Vaccine Market Size by Type
  2.3.1 Global COVID-19 RNA Vaccine Market Size Market Share by Type (2024-2029)
  2.3.2 Global COVID-19 RNA Vaccine Market Size Growth Rate by Type (2024-2029)
2.4 COVID-19 RNA Vaccine Segment by Application
  2.4.1 Pharmaceutical And Biotechnology Companies
  2.4.2 Hospital
  2.4.3 Academic And Research Organizations
  2.4.4 Other
2.5 COVID-19 RNA Vaccine Market Size by Application
  2.5.1 Global COVID-19 RNA Vaccine Market Size Market Share by Application (2024-2029)
  2.5.2 Global COVID-19 RNA Vaccine Market Size Growth Rate by Application (2024-2029)

3 COVID-19 RNA VACCINE KEY PLAYERS

3.1 Date of Key Players Enter into COVID-19 RNA Vaccine
3.2 Key Players COVID-19 RNA Vaccine Product Offered
3.3 Key Players COVID-19 RNA Vaccine Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players COVID-19 RNA Vaccine Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 COVID-19 RNA VACCINE BY REGIONS

4.1 COVID-19 RNA Vaccine Market Size by Regions (2024-2029)
4.2 United States COVID-19 RNA Vaccine Market Size Growth (2024-2029)
4.3 China COVID-19 RNA Vaccine Market Size Growth (2024-2029)
4.4 Europe COVID-19 RNA Vaccine Market Size Growth (2024-2029)
4.5 Rest of World COVID-19 RNA Vaccine Market Size Growth (2024-2029)

5 UNITED STATES

5.1 United States COVID-19 RNA Vaccine Market Size by Type (2024-2029)
5.2 United States COVID-19 RNA Vaccine Market Size by Application (2024-2029)

6 EUROPE

6.1 Europe COVID-19 RNA Vaccine Market Size by Type (2024-2029)
6.2 Europe COVID-19 RNA Vaccine Market Size by Application (2024-2029)

7 CHINA

7.1 China COVID-19 RNA Vaccine Market Size by Type (2024-2029)
7.2 China COVID-19 RNA Vaccine Market Size by Application (2024-2029)

8 REST OF WORLD

8.1 Rest of World COVID-19 RNA Vaccine Market Size by Type (2024-2029)
8.2 Rest of World COVID-19 RNA Vaccine Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN COVID-19 RNA VACCINE

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 MODERNA
  11.1.1 MODERNA Company Details
  11.1.2 MODERNA COVID-19 RNA Vaccine Product Offered
  11.1.3 MODERNA COVID-19 RNA Vaccine Market Size (2023 VS 2029)
  11.1.4 MODERNA Main Business Overview
  11.1.5 MODERNA News
11.2 CureVac
  11.2.1 CureVac Company Details
  11.2.2 CureVac COVID-19 RNA Vaccine Product Offered
  11.2.3 CureVac COVID-19 RNA Vaccine Market Size (2023 VS 2029)
  11.2.4 CureVac Main Business Overview
  11.2.5 CureVac News
11.3 Zydus Cadila
  11.3.1 Zydus Cadila Company Details
  11.3.2 Zydus Cadila COVID-19 RNA Vaccine Product Offered
  11.3.3 Zydus Cadila COVID-19 RNA Vaccine Market Size (2023 VS 2029)
  11.3.4 Zydus Cadila Main Business Overview
  11.3.5 Zydus Cadila News
11.4 BioNTech
  11.4.1 BioNTech Company Details
  11.4.2 BioNTech COVID-19 RNA Vaccine Product Offered
  11.4.3 BioNTech COVID-19 RNA Vaccine Market Size (2023 VS 2029)
  11.4.4 BioNTech Main Business Overview
  11.4.5 BioNTech News
11.5 Stermirna
  11.5.1 Stermirna Company Details
  11.5.2 Stermirna COVID-19 RNA Vaccine Product Offered
  11.5.3 Stermirna COVID-19 RNA Vaccine Market Size (2023 VS 2029)
  11.5.4 Stermirna Main Business Overview
  11.5.5 Stermirna News
...

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. COVID-19 RNA Vaccine Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of Being Developed
Table 3. Major Players of Preclinical
Table 4. Major Players of Clinical I
Table 5. Major Players of Clinical II
Table 6. Global COVID-19 RNA Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 7. Global COVID-19 RNA Vaccine Market Size Market Share by Type (2024-2029)
Table 8. Global COVID-19 RNA Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 9. Global COVID-19 RNA Vaccine Market Size Market Share by Application (2024-2029)
Table 10. Date of Global Key Players Enter into COVID-19 RNA Vaccine Market
Table 11. Global Key Players COVID-19 RNA Vaccine Product Offered
Table 12. Key Players COVID-19 RNA Vaccine Funding/Investment ($ Millions)
Table 13. Funding/Investment by Regions
Table 14. Funding/Investment by End Industry
Table 15. Key Players COVID-19 RNA Vaccine Valuation & Market Capitalization ($ Millions)
Table 16. Key Players Mergers & Acquisitions, Expansion Plans
Table 17. COVID-19 RNA Vaccine New Product/Technology Launches
Table 18. COVID-19 RNA Vaccine Industry Partnerships, Agreements, and Collaborations
Table 19. COVID-19 RNA Vaccine Industry Mergers and Acquisitions
Table 20. Global COVID-19 RNA Vaccine Market Size by Regions 2024-2029 ($ Millions)
Table 21. Global COVID-19 RNA Vaccine Market Size Market Share by Regions 2024-2029
Table 22. United States COVID-19 RNA Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 23. United States COVID-19 RNA Vaccine Market Size Market Share by Type (2024-2029)
Table 24. United States COVID-19 RNA Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 25. United States COVID-19 RNA Vaccine Market Size Market Share by Application (2024-2029)
Table 26. Europe COVID-19 RNA Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 27. Europe COVID-19 RNA Vaccine Market Size Market Share by Type (2024-2029)
Table 28. Europe COVID-19 RNA Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 29. Europe COVID-19 RNA Vaccine Market Size Market Share by Application (2024-2029)
Table 30. China COVID-19 RNA Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 31. China COVID-19 RNA Vaccine Market Size Market Share by Type (2024-2029)
Table 32. China COVID-19 RNA Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 33. China COVID-19 RNA Vaccine Market Size Market Share by Application (2024-2029)
Table 34. Rest of World COVID-19 RNA Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 35. Rest of World COVID-19 RNA Vaccine Market Size Market Share by Type (2024-2029)
Table 36. Rest of World COVID-19 RNA Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 37. Rest of World COVID-19 RNA Vaccine Market Size Market Share by Application (2024-2029)
Table 38. Key Market Drivers & Growth Opportunities of COVID-19 RNA Vaccine
Table 39. Key Market Challenges & Risks of COVID-19 RNA Vaccine
Table 40. Key Industry Trends of COVID-19 RNA Vaccine
Table 41. Company A Company Details
Table 42. Companies Invested by Company A
Table 43. Company A Key Development and Market Layout
Table 44. Company B Company Details
Table 45. Companies Invested by Company B
Table 46. Company B Key Development and Market Layout
Table 47. Company C Company Details
Table 48. Companies Invested by Company C
Table 49. Company C Key Development and Market Layout
Table 50. Company C Company Details
Table 51. Companies Invested by Company C
Table 52. Company C Key Development and Market Layout
Table 53. MODERNA Basic Information, Head Office, Major Market Areas and Its Competitors
Table 54. MODERNA COVID-19 RNA Vaccine Market Size (2023 VS 2029)
Table 55. CureVac Basic Information, Head Office, Major Market Areas and Its Competitors
Table 56. CureVac COVID-19 RNA Vaccine Market Size (2023 VS 2029)
Table 57. Zydus Cadila Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. Zydus Cadila COVID-19 RNA Vaccine Market Size (2023 VS 2029)
Table 59. BioNTech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. BioNTech COVID-19 RNA Vaccine Market Size (2023 VS 2029)
Table 61. Stermirna Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. Stermirna COVID-19 RNA Vaccine Market Size (2023 VS 2029)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of COVID-19 RNA Vaccine
Figure 2. COVID-19 RNA Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global COVID-19 RNA Vaccine Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. COVID-19 RNA Vaccine Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global COVID-19 RNA Vaccine Market Size Market Share by Type (2024-2029)
Figure 9. Global Being Developed Market Size Growth Rate
Figure 10. Global Preclinical Market Size Growth Rate
Figure 11. Global Clinical I Market Size Growth Rate
Figure 12. Global Clinical II Market Size Growth Rate
Figure 13. COVID-19 RNA Vaccine in Pharmaceutical And Biotechnology Companies
Figure 14. Global COVID-19 RNA Vaccine Market: Pharmaceutical And Biotechnology Companies (2024-2029) ($ Millions)
Figure 15. COVID-19 RNA Vaccine in Hospital
Figure 16. Global COVID-19 RNA Vaccine Market: Hospital (2024-2029) ($ Millions)
Figure 17. COVID-19 RNA Vaccine in Academic And Research Organizations
Figure 18. Global COVID-19 RNA Vaccine Market: Academic And Research Organizations (2024-2029) ($ Millions)
Figure 19. COVID-19 RNA Vaccine in Other
Figure 20. Global COVID-19 RNA Vaccine Market: Other (2024-2029) ($ Millions)
Figure 21. Global COVID-19 RNA Vaccine Market Size Market Share by Application (2024-2029)
Figure 22. Global COVID-19 RNA Vaccine Market Size in Pharmaceutical And Biotechnology Companies Growth Rate
Figure 23. Global COVID-19 RNA Vaccine Market Size in Hospital Growth Rate
Figure 24. Global COVID-19 RNA Vaccine Market Size in Academic And Research Organizations Growth Rate
Figure 25. Global COVID-19 RNA Vaccine Market Size in Other Growth Rate
Figure 26. Funding/Investment
Figure 27. Global COVID-19 RNA Vaccine Market Size Market Share by Regions 2024-2029
Figure 28. United States COVID-19 RNA Vaccine Market Size 2024-2029 ($ Millions)
Figure 29. China COVID-19 RNA Vaccine Market Size 2024-2029 ($ Millions)
Figure 30. Europe COVID-19 RNA Vaccine Market Size 2024-2029 ($ Millions)
Figure 31. Rest of World COVID-19 RNA Vaccine Market Size 2024-2029 ($ Millions)
Figure 32. United States COVID-19 RNA Vaccine Consumption Market Share by Type in 2029
Figure 33. United States COVID-19 RNA Vaccine Market Size Market Share by Application in 2029
Figure 34. China COVID-19 RNA Vaccine Consumption Market Share by Type in 2029
Figure 35. China COVID-19 RNA Vaccine Market Size Market Share by Application in 2029
Figure 36. Europe COVID-19 RNA Vaccine Consumption Market Share by Type in 2029
Figure 37. Europe COVID-19 RNA Vaccine Market Size Market Share by Application in 2029
Figure 38. Rest of World COVID-19 RNA Vaccine Consumption Market Share by Type in 2029
Figure 39. Rest of World COVID-19 RNA Vaccine Market Size Market Share by Application in 2029